Data / Form D filings / Sudo Biosciences, Inc.
Sudo Biosciences, Inc.: Form D filings
Sudo Biosciences, Inc., a technology company in Carmel, IN, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on February 15, 2024, reports $63.6 million sold of a $161.8 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10401 N. MERIDIAN STREET, SUITE 225, Carmel, IN, 46290
- Phone
- (317) 564-8990
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1860521
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Amendment | $161,763,255 | $63,596,587 | $98,166,668 | 15 | Dec 15, 2023 | sec.gov |
| Dec 28, 2023 | New notice | $141,013,255 | $53,346,588 | $87,666,667 | 12 | Dec 15, 2023 | sec.gov |
| Mar 2, 2022 | Amendment | $22,250,000 | $22,250,000 | 6 | Apr 20, 2021 | sec.gov | |
| May 5, 2021 | New notice | $10,000,000 | $9,523,810 | $476,190 | 1 | Apr 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edd Fleming | Director | |
| Chris Gagliardi | Director | |
| David Johnson | Director | |
| Scott Byrd | Executive Officer, Director | |
| Shinichiro Fuse | Director | |
| Daniel Estes | Director |
Other technology companies in Indiana that filed recently
- Atlis Health, LLC $250,000 · Oct 20, 2026
- MyDeen, Inc. $140,000 · Oct 14, 2026
- StarLifter, Inc. $4 million · Oct 8, 2026
- DONNAKYLE, INC. $50,000 · Oct 7, 2026
- Overfuel Inc. $2.9 million · Oct 7, 2026
- Aerovy Mobility, Inc. $6.4 million · Sep 14, 2026
Every Form D from the week of Feb 12, 2024 · All recent filings in Indiana · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Sudo Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.